Cargando…
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System
Patients with glioblastoma (GB), a highly aggressive brain tumor, have a median survival of 14.6 months following neurosurgical resection and adjuvant chemoradiotherapy. Quiescent GB cancer stem cells (CSCs) invariably cause local recurrence. These GB CSCs can be identified by embryonic stem cell ma...
Autores principales: | Tan, David C. H., Roth, Imogen M., Wickremesekera, Agadha C., Davis, Paul F., Kaye, Andrew H., Mantamadiotis, Theo, Stylli, Stanley S., Tan, Swee T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912312/ https://www.ncbi.nlm.nih.gov/pubmed/31683669 http://dx.doi.org/10.3390/cells8111364 |
Ejemplares similares
-
The Renin–Angiotensin System in the Tumor Microenvironment of Glioblastoma
por: O’Rawe, Michael, et al.
Publicado: (2021) -
Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
por: Roth, Imogen M., et al.
Publicado: (2019) -
Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin–Angiotensin System
por: Bradshaw, Amy Ruth, et al.
Publicado: (2016) -
Expression of Components of the Renin-Angiotensin System by the Putative Stem Cell Population Within WHO Grade I Meningioma
por: Shivapathasundram, Ganeshwaran, et al.
Publicado: (2019) -
Cancer Stem Cells in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)